Quick answer: a nicotine prescription is not required for every Australian adult in every circumstance. Under current Therapeutic Goods Administration (TGA) rules, an adult may be able to access a Schedule 3 therapeutic vape containing no more than 20 mg/mL of nicotine, for smoking cessation or management of nicotine dependence, after a pharmacist’s assessment where state or territory law permits that route. A prescription is required for Schedule 4 products above 20 mg/mL and no more than 50 mg/mL, for all therapeutic vapes where the local jurisdiction does not permit Schedule 3 supply, and for supply to a person under 18. Concentrations above 50 mg/mL are not permitted. Some jurisdictions do not permit supply to an under-18 even with a prescription, and supply to a person under 16 has an additional TGA access-pathway requirement.
Last checked: 16 August 2026. This guide explains the regulatory pathways; it is not medical advice and cannot determine whether a therapeutic vape is suitable for you. Therapeutic vapes are unapproved goods, and neither eligibility for a pathway nor a prescription guarantees that a pharmacist will supply a product.
Which pharmacy pathway applies?
The most useful starting point is age, nicotine concentration and the law in the state or territory where supply would occur. The table summarises the current federal framework. A pharmacist or prescriber still needs to confirm the applicable pathway and conditions.
| Situation | Likely first contact | Prescription status | Important condition | Official source |
|---|---|---|---|---|
| Adult, nicotine concentration of 20 mg/mL or less | Participating pharmacist | May not require a prescription | Supply must be for smoking cessation or management of nicotine dependence, be permitted by the applicable state or territory, and pass the pharmacist’s assessment. | TGA pharmacy guidance (AU-C1) |
| Adult, nicotine concentration above 20 mg/mL and no more than 50 mg/mL | Medical or nurse practitioner prescriber | Prescription required | The pharmacy supplies the Schedule 4 product only through the applicable prescription pathway. | TGA pharmacy guidance (AU-C2) |
| Any product above 50 mg/mL | Stop and verify the product information | Not an available prescription branch | Vapes above 50 mg/mL are not permitted under the current TGA framework. | TGA pharmacy guidance (AU-C2) |
| Adult in a jurisdiction that does not permit Schedule 3 supply | Medical or nurse practitioner prescriber | Prescription required | Local law can make the prescription route necessary even at 20 mg/mL or less. | TGA pharmacy guidance (AU-C2) |
| Person under 18 | Medical or nurse practitioner prescriber | Prescription required under the federal pathway | Some state or territory laws still prohibit supply to an under-18. For a person under 16, supply also requires SAS B approval or an Authorised Prescriber pathway. | TGA pharmacy guidance (AU-C3) |
This is a pathway guide, not an eligibility test. Nicotine concentration alone does not settle the question because age, product status, local law and professional assessment remain relevant.
How the pharmacist-only pathway works
Where Schedule 3 supply is permitted, an adult can ask a participating pharmacy about a therapeutic vape containing no more than 20 mg/mL of nicotine for smoking cessation or management of nicotine dependence. The pharmacist must assess the request and apply the authorised-supply conditions. A self-service checkout, an overseas listing or a general retailer is not a substitute for that consultation.
Not every pharmacy participates or stocks therapeutic vapes. Pharmacists are not compelled to stock them, and a pharmacist may decide that the requested supply is not appropriate under the applicable conditions. A referral to a prescriber is therefore a possible outcome even when the concentration is within the Schedule 3 threshold.
When a prescription is required
A valid prescription from a medical practitioner or nurse practitioner is required for a Schedule 4 therapeutic vape above 20 mg/mL and no more than 50 mg/mL. The prescription route also applies when a state or territory does not permit pharmacist-only Schedule 3 supply. A concentration above 50 mg/mL is not another prescription tier; it is not permitted under the current framework.
Under-18 supply follows the prescription pathway at federal level, but that does not override a state or territory prohibition. For a person under 16, TGA guidance also requires SAS B approval or an Authorised Prescriber pathway. A parent, carer or young person should not assume that a prescription alone makes supply lawful; the prescriber and pharmacist need to confirm both the TGA pathway and the local rules.
What the notified vape list does and does not mean
Pharmacies may supply only therapeutic vaping goods included in the TGA’s notified vape framework. Notification means the sponsor has declared that the goods meet the applicable standards. It does not mean that the product has been included in the Australian Register of Therapeutic Goods or evaluated by the TGA for quality, safety, efficacy or performance.
That distinction prevents a notified product from being described as regulator-approved. The notified list is part of the legal supply framework, but it does not convert an unapproved therapeutic good into an ARTG-listed medicine or guarantee that it is suitable for an individual.
What to prepare before speaking with a pharmacist or prescriber
You do not need to choose a brand or strength before asking which route applies. It is more useful to prepare accurate information that lets the professional identify the relevant pathway:
- your age and the state or territory where supply would occur;
- whether you currently smoke or use nicotine and what you want help with;
- the labelled nicotine concentration of any product you already use, if known;
- the packaging or product name if the pharmacist needs to check notified status;
- medicines, health conditions or other information the professional asks for; and
- questions about follow-up, storage, use and disposal.
Do not guess the nicotine concentration from a puff-count claim or product name. If the label is missing or unclear, say that directly rather than treating an online description as verified evidence.
How this page fits with Australia’s wider vaping rules
This page answers the prescription-versus-pharmacist pathway question. For the broader federal framework and public-use context, see the current guide to vaping legality in Australia. If your question is whether lawful supply is possible at all, the separate guide on buying vapes under Australia’s pharmacy rules covers that higher-level decision. The explanation of lawful supply channels and listing checks deals with seller verification rather than clinical access.
Keeping those tasks separate matters. A lawful supply channel does not prove that a particular product is suitable, while a prescription does not prove that every pharmacy stocks the product or that local law permits every form of supply.
What should you do next?
If you are 18 or older, the product is labelled at 20 mg/mL or less, and the purpose is smoking cessation or management of nicotine dependence, ask a participating pharmacist whether the Schedule 3 pathway is permitted where you live and what its assessment requires. For a product above 20 mg/mL and no more than 50 mg/mL, where the pharmacist-only route is unavailable, or where supply is for someone under 18, ask a medical or nurse practitioner prescriber which pathway and additional approvals apply. Do not treat a product above 50 mg/mL as eligible for the prescription branch.
Use the current TGA guidance as the final reference point. Do not rely on an old article, a retailer promise or a product listing to decide that a prescription is unnecessary. The correct outcome depends on the rules and professional assessment in force when supply occurs.
References
- Therapeutic Goods Administration, Supplying therapeutic vapes in pharmacies, published 10 October 2025.
- Therapeutic Goods Administration, Vaping Hub.
- Therapeutic Goods Administration, Therapeutic vapes available without a prescription following consultation with a pharmacist.
- Australian Government Department of Health, Disability and Ageing, Vaping laws.
Leave a comment